Psychosis and substance abuse increase the COVID-19 mortality risk

Ana Catalan1,2,3,4, Claudia Aymerich1, Amaia Bilbao5,6,7

  • 1Osakidetza Basque Health Service, Department of Psychiatry, Basurto University Hospital, Bilbao, Spain.

Psychological Medicine
|April 12, 2022
PubMed

Insights

Patients with psychotic disorders faced higher COVID-19 mortality and hospitalization rates. Affective disorders were associated with lower mortality during the pandemic.

Area of Science:

  • Epidemiology
  • Public Health
  • Psychiatry

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic posed significant global health challenges.
  • Elevated mortality rates were observed in specific risk groups, notably individuals with pre-existing mental health conditions.

Purpose of the Study:

  • To investigate the association between pre-existing mental disorders and COVID-19 outcomes.
  • To determine factors influencing COVID-19-related mortality and hospital admission rates in a defined population.

Main Methods:

  • Retrospective analysis of electronic health records from March 2020 to March 2021 in the Basque Country.
  • COVID-19 cases identified via positive reverse transcription-polymerase chain reaction (PCR) tests.
  • Statistical analysis using logistic regression and multilevel models to assess mortality and hospitalization risk factors.

Main Results:

  • Increased COVID-19 mortality rates were observed in patients with psychotic disorders (adjusted OR: 1.45) and substance abuse (adjusted OR: 1.88).
  • Patients with affective disorders showed a decreased mortality rate (adjusted OR: 0.80).
  • Higher hospital admission rates for COVID-19 were noted in psychosis (adjusted OR: 2.90) and anxiety disorder groups (adjusted OR: 1.54).

Conclusions:

  • Pre-existing psychotic disorders were linked to increased COVID-19 mortality and hospitalization rates.
  • Affective disorders were associated with a decreased mortality rate among hospitalized COVID-19 patients.
Abstract

Related Concept Videos

Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
232
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
214
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
492
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.1K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
225
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
234